Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice

Giuseppe Lattanzio, Claude Libert, Massimo Aquilina, Manuela Cappelletti, Gennaro Ciliberto, Piero Musiani, Valeria Poli

Research output: Contribution to journalArticlepeer-review


Interleukin (IL)-6 is known to be an essential growth factor for myeloma cells, both in vitro and in vivo. In mice, IL-6 is required for development of B cell tumors upon infection with a retrovirus expressing the myc/raf oncogenes. In the present study, we used the pristane-oil-induced plasmacytoma model, which more closely mimics tumor transformation and progression in human multiple myeloma. Also using this system, we found that IL-6-deficient BALB/c mice are protected against tumor development. Although the pristane-induced inflammatory reaction was less pronounced in IL-6- deficient mice versus their wild-type littermates, both B cell differentiation and plasma cell formation took place, and even morphological evidence of plasma cell transformation was detected, albeit at a low frequency. However, in the absence of IL-6, there were never signs of uncontrolled proliferation of either normal B lymphocytes or tumor cells, suggesting that the role of IL-6 in murine plasmacytoma and possibly also in human multiple myeloma is to ensure abnormal survival and proliferation of previously transformed tumor cells and therefore tumor development and progression.

Original languageEnglish
Pages (from-to)689-696
Number of pages8
JournalAmerican Journal of Pathology
Issue number3
Publication statusPublished - Sep 1997

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice'. Together they form a unique fingerprint.

Cite this